AMPK signalling in health and disease

被引：608

作者：

Carling, David ^{[1
]}

机构：

[1] Imperial Coll, Hammersmith Hosp, MRC London Inst Med Sci, London W12 0NN, England

来源：

CURRENT OPINION IN CELL BIOLOGY | 2017年 / 45卷

基金：

英国生物技术与生命科学研究理事会; 英国医学研究理事会;

关键词：

ACTIVATED PROTEIN-KINASE; PARKINSON-WHITE-SYNDROME; GAMMA-SUBUNIT ISOFORMS; SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; STRUCTURAL BASIS; UPSTREAM KINASE; VENTRICULAR PREEXCITATION; CARDIAC-HYPERTROPHY; MUTATION;

D O I：

10.1016/j.ceb.2017.01.005

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

In eukaryotic cells AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance. AMPK responds to changes in intracellular adenine nucleotide levels, being activated by an increase in AMP/ADP relative to ATP. Activation of AMPK increases the rate of catabolic (ATP-generating) pathways and decreases the rate of anabolic (ATP-utilising) pathways. In addition to its role in maintaining intracellular energy balance, AMPK regulates whole body energy metabolism. Given its key role in controlling energy homeostasis, AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases, including type 2 diabetes and, more recently, cancer. Here I review the regulation of AMPK and its potential as a target for therapeutic intervention in human disease.

引用

页码：31 / 37

页数：7

共 51 条

[1] Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy [J].

Arad, M ;

Moskowitz, IP ;

Patel, VV ;

Ahmad, F ;

Perez-Atayde, AR ;

Sawyer, DB ;

Walter, M ;

Li, GH ;

Burgon, PG ;

Maguire, CT ;

Stapleton, D ;

Schmitt, JP ;

Guo, XX ;

Pizard, A ;

Kupershmidt, S ;

Roden, DM ;

Berul, CI ;

Seidman, CE ;

Seidman, JG .

CIRCULATION, 2003, 107 (22) :2850-2856

[2] Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy [J].

Arad, M ;

Benson, DW ;

Perez-Atayde, AR ;

McKenna, WJ ;

Sparks, EA ;

Kanter, RJ ;

McGarry, K ;

Seidman, JG ;

Seidman, CE .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :357-362

[3] Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis [J].

Blair, E ;

Redwood, C ;

Ashrafian, H ;

Oliveira, M ;

Broxholme, J ;

Kerr, B ;

Salmon, A ;

Östman-Smith, I ;

Watkins, H .

HUMAN MOLECULAR GENETICS, 2001, 10 (11) :1215-1220

[4] OXIDATIVE-PHOSPHORYLATION AND PHOTOPHOSPHORYLATION [J].

BOYER, PD ;

CHANCE, B ;

ERNSTER, L ;

MITCHELL, P ;

RACKER, E ;

SLATER, EC .

ANNUAL REVIEW OF BIOCHEMISTRY, 1977, 46 :955-1026

[5] Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle [J].

Bultot, Laurent ;

Jensen, Thomas E. ;

Lai, Yu-Chiang ;

Madsen, Agnete L. B. ;

Collodet, Caterina ;

Kviklyte, Samanta ;

Deak, Maria ;

Yavari, Arash ;

Foretz, Marc ;

Ghaffari, Sahar ;

Bellahcene, Mohamed ;

Ashrafian, Houman ;

Rider, Mark H. ;

Richter, Erik A. ;

Sakamoto, Kei .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 311 (04) :E706-E719

[6] Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms [J].

Calabrese, Matthew F. ;

Rajamohan, Francis ;

Harris, Melissa S. ;

Caspers, Nicole L. ;

Magyar, Rachelle ;

Withka, Jane M. ;

Wang, Hong ;

Borzilleri, Kris A. ;

Sahasrabudhe, Parag V. ;

Hoth, Lise R. ;

Geoghegan, Kieran F. ;

Han, Seungil ;

Brown, Janice ;

Subashi, Timothy A. ;

Reyes, Allan R. ;

Frisbie, Richard K. ;

Ward, Jessica ;

Miller, Russell A. ;

Landro, James A. ;

Londregan, Allyn T. ;

Carpino, Philip A. ;

Cabral, Shawn ;

Smith, Aaron C. ;

Conn, Edward L. ;

Cameron, Kimberly O. ;

Qiu, Xiayang ;

Kurumbail, Ravi G. .

STRUCTURE, 2014, 22 (08) :1161-1172

[7] Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy [J].

Cameron, Kimberly O. ;

Kung, Daniel W. ;

Kalgutkar, Amit S. ;

Kurumbail, Ravi G. ;

Miller, Russell ;

Salatto, Christopher T. ;

Ward, Jessica ;

Withka, Jane M. ;

Bhattacharya, Samit K. ;

Boehm, Markus ;

Borzilleri, Kris A. ;

Brown, Janice A. ;

Calabrese, Matthew ;

Caspers, Nicole L. ;

Cokorinos, Emily ;

Conn, Edward L. ;

Dowling, Matthew S. ;

Edmonds, David J. ;

Eng, Heather ;

Fernando, Dilinie P. ;

Frisbie, Richard ;

Hepworth, David ;

Landro, James ;

Mao, Yuxia ;

Rajamohan, Francis ;

Reyes, Allan R. ;

Rose, Colin R. ;

Ryder, Tim ;

Shavnya, Andre ;

Smith, Aaron C. ;

Tu, Meihua ;

Wolford, Angela C. ;

Xiao, Jun .

JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (17) :8068-8081

[8] AMP-activated protein kinase: new regulation, new roles? [J].

Carling, David ;

Thornton, Claire ;

Woods, Angela ;

Sanders, Matthew J. .

BIOCHEMICAL JOURNAL, 2012, 445 :11-27

[9]

Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/NCHEMBIO.610, 10.1038/nchembio.610]

[10] Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding [J].

Cheung, PCF ;

Salt, IP ;

Davies, SP ;

Hardie, DG ;

Carling, D .

BIOCHEMICAL JOURNAL, 2000, 346 :659-669

← 1 2 3 4 5 6 →